7TZF image
Deposition Date 2022-02-15
Release Date 2022-03-23
Last Version Date 2025-05-21
Entry Detail
PDB ID:
7TZF
Title:
Human Amylin3 Receptor in complex with Gs and rat amylin peptide
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Lama glama (Taxon ID: 9844)
Rattus norvegicus (Taxon ID: 10116)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.40 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Guanine nucleotide-binding protein G(s) subunit alpha isoforms short
Gene (Uniprot):GNAS
Chain IDs:D (auth: A)
Chain Length:394
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
Gene (Uniprot):GNB1
Chain IDs:E (auth: B)
Chain Length:350
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Receptor activity-modifying protein 3
Gene (Uniprot):RAMP3
Chain IDs:A (auth: E)
Chain Length:149
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
Gene (Uniprot):GNG2
Chain IDs:F (auth: G)
Chain Length:71
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:nanobody 35
Chain IDs:G (auth: N)
Chain Length:138
Number of Molecules:1
Biological Source:Lama glama
Polymer Type:polypeptide(L)
Molecule:amylin peptide
Gene (Uniprot):Iapp
Chain IDs:B (auth: P)
Chain Length:38
Number of Molecules:1
Biological Source:Rattus norvegicus
Polymer Type:polypeptide(L)
Molecule:Calcitonin receptor
Gene (Uniprot):CALCR
Chain IDs:C (auth: R)
Chain Length:501
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
A structural basis for amylin receptor phenotype.
Science 375 eabm9609 eabm9609 (2022)
PMID: 35324283 DOI: 10.1126/science.abm9609

Abstact

Amylin receptors (AMYRs) are heterodimers of the calcitonin (CT) receptor (CTR) and one of three receptor activity-modifying proteins (RAMPs), AMY1R, AMY2R, and AMY3R. Selective AMYR agonists and dual AMYR/CTR agonists are being developed as obesity treatments; however, the molecular basis for peptide binding and selectivity is unknown. We determined the structure and dynamics of active AMYRs with amylin, AMY1R with salmon CT (sCT), AMY2R with sCT or human CT (hCT), and CTR with amylin, sCT, or hCT. The conformation of amylin-bound complexes was similar for all AMYRs, constrained by the RAMP, and an ordered midpeptide motif that we call the bypass motif. The CT-bound AMYR complexes were distinct, overlapping the CT-bound CTR complexes. Our findings indicate that activation of AMYRs by CT-based peptides is distinct from their activation by amylin-based peptides. This has important implications for the development of AMYR therapeutics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures